| Foamy macrophages and the progression of the human tuberculosis granuloma DG Russell, PJ Cardona, MJ Kim, S Allain, F Altare Nature immunology 10 (9), 943-948, 2009 | 1009 | 2009 |
| Foamy Macrophages from Tuberculous Patients' Granulomas Constitute a Nutrient-Rich Reservoir for M. tuberculosis Persistence P Peyron, J Vaubourgeix, Y Poquet, F Levillain, C Botanch, F Bardou, ... PLoS pathogens 4 (11), e1000204, 2008 | 848 | 2008 |
| LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement U Mack, GB Migliori, M Sester, HL Rieder, S Ehlers, D Goletti, A Bossink, ... European Respiratory Journal 33 (5), 956-973, 2009 | 825 | 2009 |
| A multistage tuberculosis vaccine that confers efficient protection before and after exposure C Aagaard, T Hoang, J Dietrich, PJ Cardona, A Izzo, G Dolganov, ... Nature medicine 17 (2), 189-194, 2011 | 642 | 2011 |
| The global burden of tuberculosis: results from the Global Burden of Disease Study 2015 HH Kyu, ER Maddison, NJ Henry, JE Mumford, R Barber, C Shields, ... The Lancet Infectious Diseases 18 (3), 261-284, 2018 | 374 | 2018 |
| The live Mycobacterium tuberculosis phoP mutant strain is more attenuated than BCG and confers protective immunity against tuberculosis in mice and guinea pigs C Martin, A Williams, R Hernandez-Pando, PJ Cardona, E Gormley, ... Vaccine 24 (17), 3408-3419, 2006 | 300 | 2006 |
| Construction, characterization and preclinical evaluation of MTBVAC, the first live-attenuated M. tuberculosis-based vaccine to enter clinical trials A Arbues, JI Aguilo, J Gonzalo-Asensio, D Marinova, S Uranga, ... Vaccine 31 (42), 4867-4873, 2013 | 288 | 2013 |
| Risk factors for lower airway bacterial colonization in chronic bronchitis E Monso, A Rosell, G Bonet, J Manterola, PJ Cardona, J Ruiz, J Morera European Respiratory Journal 13 (2), 338-342, 1999 | 263 | 1999 |
| Ibuprofen therapy resulted in significantly decreased tissue bacillary loads and increased survival in a new murine experimental model of active tuberculosis C Vilaplana, E Marzo, G Tapia, J Diaz, V Garcia, PJ Cardona The Journal of infectious diseases 208 (2), 199-202, 2013 | 236 | 2013 |
| RUTI: a new chance to shorten the treatment of latent tuberculosis infection PJ Cardona Tuberculosis 86 (3-4), 273-289, 2006 | 224 | 2006 |
| Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI® C Vilaplana, E Montané, S Pinto, AM Barriocanal, G Domenech, F Torres, ... Vaccine 28 (4), 1106-1116, 2010 | 184 | 2010 |
| A dynamic reinfection hypothesis of latent tuberculosis infection PJ Cardona Infection 37, 80-86, 2009 | 181 | 2009 |
| Comparative evaluation of initial and new versions of the Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for direct detection of Mycobacterium tuberculosis in … F Gamboa, G Fernandez, E Padilla, JM Manterola, J Lonca, PJ Cardona, ... Journal of clinical microbiology 36 (3), 684-689, 1998 | 160 | 1998 |
| The burden of disease in Spain: Results from the Global Burden of Disease 2016 JB Soriano, D Rojas-Rueda, J Alonso, JM Antó, PJ Cardona, ... Medicina Clínica (English Edition) 151 (5), 171-190, 2018 | 155 | 2018 |
| Patogénesis de la tuberculosis y otras micobacteriosis PJ Cardona Enfermedades infecciosas y microbiologia clinica 36 (1), 38-46, 2018 | 152 | 2018 |
| Evolution of granulomas in lungs of mice infected aerogenically with Mycobacterium tuberculosis PJ Cardona, R Llatjos, S Gordillo, J Diaz, I Ojanguren, A Ariza, V Ausina Scandinavian journal of immunology 52 (2), 156-163, 2000 | 147 | 2000 |
| Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis … AS Nell, E D’lom, P Bouic, M Sabaté, R Bosser, J Picas, M Amat, ... PloS one 9 (2), e89612, 2014 | 142 | 2014 |
| On the nature of Mycobacterium tuberculosis-latent bacilli PJ Cardona, J Ruiz-Manzano European Respiratory Journal 24 (6), 1044-1051, 2004 | 142 | 2004 |
| Role of the chemokine decoy receptor D6 in balancing inflammation, immune activation, and antimicrobial resistance in Mycobacterium tuberculosis infection D Di Liberto, M Locati, N Caccamo, A Vecchi, S Meraviglia, A Salerno, ... The Journal of experimental medicine 205 (9), 2075-2084, 2008 | 133 | 2008 |
| Granuloma encapsulation is a key factor for containing tuberculosis infection in minipigs O Gil, I Diaz, C Vilaplana, G Tapia, J Diaz, M Fort, N Caceres, S Pinto, ... PloS one 5 (4), e10030, 2010 | 132 | 2010 |
Clara PratsUniversitat Politècnica de CatalunyaVerified email at upc.edu
